109 related articles for article (PubMed ID: 7182445)
1. [Dose dependency of loop diuretics, furosemide and piretanide in the rat].
Inui S; Yamamoto M; Nakae H; Asada S
Yakugaku Zasshi; 1982 Nov; 102(11):1053-60. PubMed ID: 7182445
[No Abstract] [Full Text] [Related]
2. Micellar electrokinetic chromatography as a fast screening method for the determination of the doping agents furosemide and piretanide in urine.
Lalljie SP; Barroso MB; Steenackers D; Alonso RM; Jiménez RM; Sandra P
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(1):71-8. PubMed ID: 9029315
[TBL] [Abstract][Full Text] [Related]
3. Comparative ototoxicity of furosemide and piretanide.
Rybak LP; Whitworth C
Acta Otolaryngol; 1986; 101(1-2):59-65. PubMed ID: 3962650
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
Dodion L; Ambroes Y; Lameire N
Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacodynamics of piretanide in compromised kidney function. Dose response relationship and equipotency with furosemide].
Keller E; Reetze-Bonorden P; Rambauseck M; Pooth R
Internist (Berl); 1992 Aug; 33 Suppl 1():S36-8. PubMed ID: 1428696
[No Abstract] [Full Text] [Related]
6. Renal actions of piretanide and three other "loop" diuretics.
McNabb WR; Noormohamed FH; Brooks BA; Lant AF
Clin Pharmacol Ther; 1984 Mar; 35(3):328-37. PubMed ID: 6697640
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of inhaled piretanide on the bronchial obstructive response to ultrasonically nebulized H2O. A dose-response study.
Bianco S; Robuschi M; Vaghi A; Pieroni MG; Sestini P
Chest; 1993 Jul; 104(1):185-8. PubMed ID: 8325066
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.
Marone C; Reubi FC; Lahn W
Eur J Clin Pharmacol; 1984; 26(4):413-8. PubMed ID: 6734705
[TBL] [Abstract][Full Text] [Related]
9. Piretanide: a loop-active diuretic. Pharmacology, therapeutic efficacy and adverse effects.
Marsh JD; Smith TW
Pharmacotherapy; 1984; 4(4):170-80. PubMed ID: 6384944
[TBL] [Abstract][Full Text] [Related]
10. Comparative acute ototoxicity of loop diuretic compounds.
Rybak LP; Whitworth C; Scott V
Eur Arch Otorhinolaryngol; 1991; 248(6):353-7. PubMed ID: 1930985
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of torasemide, a new loop diuretic.
Brater DC; Leinfelder J; Anderson SA
Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
[TBL] [Abstract][Full Text] [Related]
12. Dose-related effects of furosemide, bumetanide, and piretanide on the thick ascending limb function in the rat.
Gutsche HU; Müller-Ott K; Brunkhorst R; Niedermayer W
Can J Physiol Pharmacol; 1983 Feb; 61(2):159-65. PubMed ID: 6301665
[TBL] [Abstract][Full Text] [Related]
13. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
Vasavada N; Saha C; Agarwal R
Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
[TBL] [Abstract][Full Text] [Related]
14. Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease.
Goto S; Yoshitomi H; Miyamoto A; Inoue K; Nakano M
J Pharmacobiodyn; 1980 Dec; 3(12):667-76. PubMed ID: 7277182
[TBL] [Abstract][Full Text] [Related]
15. Acute tolerance development to the diuretic effect of furosemide in the rat.
Hammarlund M; Paalzow LK
Biopharm Drug Dispos; 1985; 6(1):9-21. PubMed ID: 3986304
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
Chuen MJ; MacFadyen RJ
Am J Cardiol; 2006 Nov; 98(10):1416-7. PubMed ID: 17134642
[No Abstract] [Full Text] [Related]
17. Effect of diuretics on the tubuloglomerular feedback response.
Gutsche HU; Brunkhorst R; Müller-Ott K; Franke H; Niedermayer W
Can J Physiol Pharmacol; 1984 Apr; 62(4):412-7. PubMed ID: 6733586
[TBL] [Abstract][Full Text] [Related]
18. Renal tubular secretion of piretanide and its effects on electrolyte reabsorption and tubuloglomerular feedback mechanism.
Odlind B; Beermann B; Selén G; Persson AE
J Pharmacol Exp Ther; 1983 Jun; 225(3):742-6. PubMed ID: 6864530
[TBL] [Abstract][Full Text] [Related]
19. The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients.
Shepherd AN; Bouchier IA
Eur J Clin Pharmacol; 1985; 28(5):581-3. PubMed ID: 4043200
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
Mentz RJ; Velazquez EJ; Metra M; McKendry C; Chiswell K; Fiuzat M; Givertz MM; Voors AA; Teerlink JR; O'Connor CM
Future Cardiol; 2015 Sep; 11(5):585-95. PubMed ID: 26403536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
